“We wanted the drugs controller and the ministry of health to really go through all the data, examine everything, to double check what we have done, what Oxford has done that is safe and effective,” Adar Poonawalla, CEO of SII.
Posted from: this blog via Microsoft Flow.
No comments:
Post a Comment